ETF Managers Group’s Meridian Bioscience Inc VIVO Stock Holding History

ETF Managers Group’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,927	Closed	-$363K	–	759
2022 Q4	$363K	Sell	10,927 -1,983	-15%	-$63.9K	0.02%	406
2022 Q3	$407K	Sell	12,910 -857	-6%	-$27.8K	0.01%	502
2022 Q2	$434K	Buy	13,767 +560	+4%	+$15.1K	0.01%	534
2022 Q1	$348K	Buy	13,207 +101	+0.8%	+$2.4K	0.01%	522
2021 Q4	$264K	Sell	13,106 -2,724	-17%	-$52.2K	0.01%	601
2021 Q3	$308K	Buy	15,830 +3,050	+24%	+$60.8K	0.01%	592
2021 Q2	$288K	Sell	12,780 -35,534	-74%	-$754K	﹤0.01%	587
2021 Q1	$1.24M	Buy	48,314 +16,107	+50%	+$383K	0.02%	251
2020 Q4	$626K	Buy	32,207 +8,192	+34%	+$153K	0.01%	301
2020 Q3	$414K	Buy	24,015 +11,865	+98%	+$231K	0.01%	348
2020 Q2	$265K	Buy	+12,150	New	+$176K	0.01%	484

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

ETF Managers Group's VIVO Position: Q1 2023 in Review

ETF Managers Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 10,927 shares — an estimated $363K sold.

ETF Managers Group first reported a position in VIVO in Q2 2020 and held it in 11 quarters. The position peaked at $1.24M in Q1 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

ETF Managers Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
ETF Managers Group sold 10,927 Meridian Bioscience Inc shares in Q1 2023, an estimated $363K.
ETF Managers Group first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 11 quarters.
ETF Managers Group's Meridian Bioscience Inc position peaked at $1.24M in Q1 2021.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.